Reveal the list! The fifth batch of centralized procurement results announced

June 30, 2021

Just now, Shanghai Sunshine Pharmaceutical Purchasing Network announced the results of the fifth batch of centralized procurement; 61 procurements were successful, with an average price reduction of 56%. It involves common people's medications for hypertension, diabetes, coronary heart disease, antibiotics, gastrointestinal system medications and anti-tumor medications. According to data from the National Medical Insurance Administration, five batches of nationally organized drug procurement included a total of 218 drugs, involving an amount of 220 billion yuan, accounting for 30% of the total chemical drug purchases of public medical institutions. The Medical Insurance Bureau stated that it is expected that patients across the country will be able to use the drugs after the price has been reduced in October 2021.

Original download:

Attachment: 2. List of products to be supplied after selection in the national centralized drug procurement.pdf
Attachment: 1. Selection result table of national centralized drug procurement.pdf